Roel J.W. van Kampen

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · Breast Cancer Research and Treatment · 2013 · 250 citations

Medicine, Cancer Biology, Oncology +16

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · British Journal of Cancer · 2015 · 242 citations · Full text

Medicine, Biostatistics, Oncology +17

Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry

Roel J.W. van Kampen, Carmen Canals, Harry C. Schouten et al. · Journal of Clinical Oncology · 2011 · 215 citations · Full text

Medicine, Hematology, Oncology +16

Initiating and potentiating role of platelets in tissue factor‐induced thrombin generation in the presence of plasma: subject‐dependent variation in thrombogram characteristics

Kristof Vanschoonbeek, Marion A.H. Feijge, Roel J.W. van Kampen et al. · Journal of Thrombosis and Haemostasis · 2004 · 150 citations · Full text

Medicine, Hematology, Physiology +15

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · Annals of Oncology · 2015 · 81 citations · Full text

Medicine, Oncology, Chemotherapy +16